EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity

Ole Lagatie iD, Dax Lauwers, Harvinder Singh, Fien Vanroye iD, Daniel J Stieh, Johan Vingerhoets, Ludo Lavreys, Valérie Oriol-Mathieu, Will Colón, Chris Verhofstede, Koen Vercauteren, Dorien Van den Bossche und 1 weitere

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.00715-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Ole Lagatie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson Global Public Health Research & Development, Beerse, Belgium. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, AIDS Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen, Flanders Innovation & Entrepreneurship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While the detection of HIV infection is accomplished by several methods, the most common are serological tests that detect host antibodies produced in response to viral infection. However, the use of current serological tests may present a significant challenge to the adoption of an HIV vaccine in the future because the antibodies to HIV antigens detected in currently available tests also tend to be included as antigens in the HIV vaccines in development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1AIDS VaccinesHumansAntibodies, ViralSerologic Tests

Stichwörter der Autor:innen

antigensdiagnosticshuman immunodeficiency virusseroreactivityvaccine

Substanzen

AIDS VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Johnson & Johnson Global Public Health Research & Development, Beerse, Belgium.
  • Institute of Tropical Medicine, Antwerp, Belgium.
  • Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • Janssen Research & Development, Beerse, Belgium.
  • Ghent University, Ghent, Belgium.

ORCID-Profile: Ole Lagatie, Fien Vanroye

Förderung

  • Janssen
  • Flanders Innovation & Entrepreneurship

Zitieren

APA

Lagatie, O., Lauwers, D., Singh, H., Vanroye, F., Stieh, D. J., Vingerhoets, J., Lavreys, L., Oriol-Mathieu, V., Colón, W., Verhofstede, C., Vercauteren, K., Van den Bossche, D., & Pau, M. G. (2023). Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00715-23

Vancouver

Lagatie O, Lauwers D, Singh H, Vanroye F, Stieh DJ, Vingerhoets J, et al. Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity. Microbiology Spectrum. 2023. doi:10.1128/spectrum.00715-23

BibTeX
@article{Lagatie2023,
  author = {Lagatie, Ole and Lauwers, Dax and Singh, Harvinder and Vanroye, Fien and Stieh, Daniel J and Vingerhoets, Johan and Lavreys, Ludo and Oriol-Mathieu, Valérie and Colón, Will and Verhofstede, Chris and Vercauteren, Koen and Van den Bossche, Dorien and Pau, Maria Grazia},
  title = {Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.00715-23}
}
Kostenlos starten →